Targeting melanoma’s MCL1 bias unleashes the apoptotic potential of BRAF and ERK1/2 pathway inhibitors
- DOI
- 10.1038/s41467-019-12409-w
- Published
- 2019-11-14
- Container
- Nature Communications
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41467-019-12409-w,
title = {Targeting melanoma’s MCL1 bias unleashes the apoptotic potential of BRAF and ERK1/2 pathway inhibitors},
author = {Matthew J. Sale and Emma Minihane and Noel R. Monks and Rebecca Gilley and Frances M. Richards and Kevin P. Schifferli and Courtney L. Andersen and Emma J. Davies and Mario Aladren Vicente and Eiko Ozono and Aleksandra Markovets and Jonathan R. Dry and Lisa Drew and Vikki Flemington and Theresa Proia and Duncan I. Jodrell and Paul D. Smith and Simon J. Cook},
year = {2019},
journal = {Nature Communications},
doi = {10.1038/s41467-019-12409-w},
url = {https://doi.org/10.1038/s41467-019-12409-w}
}RIS
TY - JOUR TI - Targeting melanoma’s MCL1 bias unleashes the apoptotic potential of BRAF and ERK1/2 pathway inhibitors AU - Matthew J. Sale AU - Emma Minihane AU - Noel R. Monks AU - Rebecca Gilley AU - Frances M. Richards AU - Kevin P. Schifferli AU - Courtney L. Andersen AU - Emma J. Davies AU - Mario Aladren Vicente AU - Eiko Ozono AU - Aleksandra Markovets AU - Jonathan R. Dry AU - Lisa Drew AU - Vikki Flemington AU - Theresa Proia AU - Duncan I. Jodrell AU - Paul D. Smith AU - Simon J. Cook PY - 2019 JO - Nature Communications DO - 10.1038/s41467-019-12409-w UR - https://doi.org/10.1038/s41467-019-12409-w ER -
APA
Sale, M. J., Minihane, E., Monks, N. R., Gilley, R., Richards, F. M., Schifferli, K. P., Andersen, C. L., Davies, E. J., Vicente, M. A., Ozono, E., Markovets, A., Dry, J. R., Drew, L., Flemington, V., Proia, T., Jodrell, D. I., Smith, P. D., & Cook, S. J. (2019). Targeting melanoma’s MCL1 bias unleashes the apoptotic potential of BRAF and ERK1/2 pathway inhibitors. Nature Communications. https://doi.org/10.1038/s41467-019-12409-w
Source records
- crossref · retrieved 2026-09-26T01:48:19.905Z